What is he best known for?
The fields of study he is best known for:
- Internal medicine
- Cancer
- Surgery
Keizo Sugimachi mainly investigates Pathology, Internal medicine, Carcinoma, Surgery and Gastroenterology.
The study incorporates disciplines such as Cancer research, Metastasis and Adenocarcinoma in addition to Pathology.
His Internal medicine research integrates issues from Endocrinology and Oncology.
The concepts of his Carcinoma study are interwoven with issues in Esophagus, Carcinoembryonic antigen, Survival rate and Clinical significance.
Keizo Sugimachi works mostly in the field of Surgery, limiting it down to concerns involving Stomach and, occasionally, Toxicity.
Keizo Sugimachi has included themes like Hepatocellular carcinoma, Survival analysis, Chemotherapy and Risk factor in his Gastroenterology study.
His most cited work include:
- Laparoscopy-assisted Billroth I gastrectomy. (782 citations)
- Late phase II study of novel oral fluoropyrimidine anticancer drug S-1 (1 M tegafur–0.4 M gimestat–1 M otastat potassium) in advanced gastric cancer patients (534 citations)
- Postoperative liver failure after major hepatic resection for hepatocellular carcinoma in the modern era with special reference to remnant liver volume (367 citations)
What are the main themes of his work throughout his whole career to date?
The scientist’s investigation covers issues in Surgery, Internal medicine, Pathology, Carcinoma and Gastroenterology.
His Surgery research is multidisciplinary, incorporating perspectives in Gastrectomy, Varices and Radiology.
The Internal medicine study combines topics in areas such as Hepatectomy, Endocrinology and Oncology.
His Pathology research incorporates themes from Cancer, Metastasis and Adenocarcinoma.
His Cancer research is multidisciplinary, incorporating elements of Stomach, Lymphatic system and Cancer research.
His research in Carcinoma intersects with topics in Esophagus and Stage.
He most often published in these fields:
- Surgery (34.16%)
- Internal medicine (33.42%)
- Pathology (33.24%)
What were the highlights of his more recent work (between 2001-2020)?
- Surgery (34.16%)
- Pathology (33.24%)
- Internal medicine (33.42%)
In recent papers he was focusing on the following fields of study:
Surgery, Pathology, Internal medicine, Carcinoma and Gastroenterology are his primary areas of study.
His work investigates the relationship between Surgery and topics such as Radiology that intersect with problems in Lung.
His biological study spans a wide range of topics, including Cancer, Metastasis, Adenocarcinoma and Gene expression.
His study in Internal medicine is interdisciplinary in nature, drawing from both Endocrinology and Oncology.
His work carried out in the field of Carcinoma brings together such families of science as Esophagus, Stomach and Stage.
While the research belongs to areas of Gastroenterology, Keizo Sugimachi spends his time largely on the problem of Esophageal disease, intersecting his research to questions surrounding Esophageal cancer, Esophageal varices and Varices.
Between 2001 and 2020, his most popular works were:
- Operative morbidity of living liver donors in Japan. (237 citations)
- Angiogenic gene therapy for experimental critical limb ischemia: Acceleration of limb loss by overexpression of vascular endothelial growth factor 165 but not of fibroblast growth factor-2 (214 citations)
- Transcriptional repressor snail and progression of human hepatocellular carcinoma. (157 citations)
In his most recent research, the most cited papers focused on:
- Internal medicine
- Cancer
- Surgery
His primary areas of study are Internal medicine, Pathology, Surgery, Carcinoma and Cancer research.
His work deals with themes such as Gastroenterology, Endocrinology and Oncology, which intersect with Internal medicine.
His Pathology research includes themes of Gene expression and Adenocarcinoma.
Keizo Sugimachi works mostly in the field of Surgery, limiting it down to topics relating to Stomach and, in certain cases, Lymphatic system, Lymph node and Lymphovascular invasion, as a part of the same area of interest.
His studies deal with areas such as Esophagus and Cancer as well as Carcinoma.
Keizo Sugimachi combines subjects such as Cell, Histone H4, Carcinogenesis, Tumor suppressor gene and Tumor progression with his study of Cancer research.
This overview was generated by a machine learning system which analysed the scientist’s
body of work. If you have any feedback, you can
contact us
here.
